January 2018


Sign in or subscribe to listen

No me gusta!

The flash player was unable to start. If you have a flash blocker then try unblocking the flash content - it should be visible below.

Tim V. -

Thanks for the great review.

Does anyone fight the tPA fight anymore? One weak RCT to support its use.

Here’s a good summary of the literature:

J. Thompson D.O. -

Any comments on Hypertensive Encephalopathy? This was not mentioned as a stroke mimic. Given the tremendous pressure now a days to meet metrics and do things as fast as possible, is it reasonable or unreasonable to watch and wait for your Labetalol or Cardene to resolve symptoms, and if so, what is that time frame.
At my facility, we are pushed for a door to needle time of <60min.
Just in the past 2 weeks I have had 2 different patients present with neurologic deficits consistent with having a stroke, but ended up with diagnosis of Hypertensive Encephalopathy.
There was talk of "not lowering the blood pressure" in certain cases. I disagree leaving BP high in the face of neurologic defecits if TPA is not going to be given.
TPA is not a benign drug and it seems that the stroke neurologists will give TPA on a whim if non-contrast head CT is negative and absence of contraindications, solely to meet the metric.

Jess Mason -

We get to this in a later chapter.

To join the conversation, you need to subscribe.

Sign up today for full access to all episodes and to join the conversation.